Here, we demonstrate that the depletion of proliferating PDPN-expressing LECs significantly inhibits lymphangiogenesis in mammary tumors, resulting in decreased distant metastasis without an impact on primary tumor growth. This evidence concerns the gene PDPN and breast cancer.